Javascript must be enabled to continue!
Unveiling Hepatitis B and C Rates: Screening Program Results in Khyber Pakhtunkhwa Province, Pakistan, and Amongst Afghan Migrants
View through CrossRef
Hepatitis B and C are major health issues in developing countries such as Pakistan and Afghan-istan. The aim of this study was to determine the prevalence and effectiveness of a screening program for hepatitis B and C in a region with no existing programs, and to estimate their prev-alence in the general population in Khyber Pakhtunkhwa Province, Pakistan, as well as in Afghan refugees or migrants. A retrospective cohort study was done in the general population of Peshawar and its adjacent districts, as well as migrants from neighboring provinces of Afghani-stan, who presented to our tertiary-care health facility. A Microsoft Excel registry was created for data collection, which were analyzed using IBM SPSS via descriptive analysis, normal distribution curve histograms, and chi-squared tests. A total of 9563 individuals were screened for hepatitis (5894 males and 3669 females), including Afghan migrants in Peshawar and surrounding districts. 876 individuals tested positive for hepatitis, with 538 positive for hepatitis B (383 males and 155 females) and 330 positive for hepatitis C (198 males and 134 females). Eight individuals had a hepatitis B and C co-infection. Among the study population, the prevalence rates were 2.2% for hepatitis B and 2.3% for hepatitis C, of which the Afghan migrants accounted for 2.7% and 0.5%, respectively. According to the gender-based distribution, hepatitis B was more prevalent in males, whereas there was no significant gender-based difference for hepatitis C. Our results highlight the need for a comprehensive approach to control hepatitis B and C in Pakistan and Afghanistan. Increased awareness, improved healthcare, and preventive measures such as screening and elimination programs to prevent severe liver diseases and eradicate hepatitis are necessary.
Title: Unveiling Hepatitis B and C Rates: Screening Program Results in Khyber Pakhtunkhwa Province, Pakistan, and Amongst Afghan Migrants
Description:
Hepatitis B and C are major health issues in developing countries such as Pakistan and Afghan-istan.
The aim of this study was to determine the prevalence and effectiveness of a screening program for hepatitis B and C in a region with no existing programs, and to estimate their prev-alence in the general population in Khyber Pakhtunkhwa Province, Pakistan, as well as in Afghan refugees or migrants.
A retrospective cohort study was done in the general population of Peshawar and its adjacent districts, as well as migrants from neighboring provinces of Afghani-stan, who presented to our tertiary-care health facility.
A Microsoft Excel registry was created for data collection, which were analyzed using IBM SPSS via descriptive analysis, normal distribution curve histograms, and chi-squared tests.
A total of 9563 individuals were screened for hepatitis (5894 males and 3669 females), including Afghan migrants in Peshawar and surrounding districts.
876 individuals tested positive for hepatitis, with 538 positive for hepatitis B (383 males and 155 females) and 330 positive for hepatitis C (198 males and 134 females).
Eight individuals had a hepatitis B and C co-infection.
Among the study population, the prevalence rates were 2.
2% for hepatitis B and 2.
3% for hepatitis C, of which the Afghan migrants accounted for 2.
7% and 0.
5%, respectively.
According to the gender-based distribution, hepatitis B was more prevalent in males, whereas there was no significant gender-based difference for hepatitis C.
Our results highlight the need for a comprehensive approach to control hepatitis B and C in Pakistan and Afghanistan.
Increased awareness, improved healthcare, and preventive measures such as screening and elimination programs to prevent severe liver diseases and eradicate hepatitis are necessary.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Unveiling Hepatitis B and C Rates: Screening Program Results in Khyber Pakhtunkhwa Province, Pakistan, and Amongst Afghan Migrants
Unveiling Hepatitis B and C Rates: Screening Program Results in Khyber Pakhtunkhwa Province, Pakistan, and Amongst Afghan Migrants
Hepatitis B and C are major health issues in developing countries such as Pakistan and Afghan-istan. The aim of this study was to determine the prevalence and effectiveness of a sc...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
<b>PREVALENCE OF HAEMAPROTOZOANS AND THEIR ASSOCIATED RISK FACTORS IN DISTRICT KOHAT</b>
<b>PREVALENCE OF HAEMAPROTOZOANS AND THEIR ASSOCIATED RISK FACTORS IN DISTRICT KOHAT</b>
Aim: This work represents the general overview on heamoproyozoans in small ruminants of different area of District ,Kohat Khyber Pakhtunkhwa, Pakistan,which help in avoid the socio...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps with Rheumatologist-Pharmacist Co-management
Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps with Rheumatologist-Pharmacist Co-management
Objective: To close laboratory screening care gaps via rheumatology-pharmacy co-management in patients starting disease-modifying antirheumatic drugs. Methods: Laboratory data wer...
Hepatitis C Viremia in Patients With Hepatitis C Virus Infection
Hepatitis C Viremia in Patients With Hepatitis C Virus Infection
Sera from 103 patients were tested for hepatitis C virus RNA by nested polymerase chain reaction assay. Using primers from the highly conserved 5′untranslated region, we detected h...
Investigating the Impact of Admission Requirements on Academic Performance in Khyber Pakhtunkhwa's Medical Teaching Institutions
Investigating the Impact of Admission Requirements on Academic Performance in Khyber Pakhtunkhwa's Medical Teaching Institutions
Introduction: The effectiveness of admission criteria in predicting academic performance is critical for optimizing student success in medical education. This study investigates ho...

